Back in late 2012 when QCOR sold off 17, there was some other BS company website that stated they wanted to create a replacement for ACTHAR so that people could afford treatment.
That lasted about as long as my morning #$%$, just like this BS. Man these shorts will try anything but all they do is get me cheaper prices on the stock.
The picture looks like he just took one in the pooper. He's a #$%$ and its a shame that people sell on this stuff.
Hey, I like the company but this is far from a sure thing. Without going into detail, the latest trial results were nothing to write home about but just good enough to keep us intrigued.
Where the stock was means nothing to me. All I care about is where it's going and if we get to high single digits by 2015, I'll be more then content. GLTAL
We need the early stage biotech sector to stay hot. Look at GALE, CYTR, XOMA ect. They are moving together.Don't want to rain on the parade but like I said before, SNTA is moving with the sector and from the end of tax loss selling and not from specific news or a rethink of the latest trial results.
We need the speculative money to keep flowing until we get more data.
Much of it is the end of tax loss selling. Many of the dogs that offered a loss to go against massive gains on other equities in 2013 have done well since the beginning of 2014 because they are no longer used as write offs.
I don't think the move up is pending news driven and we will still have to wait for some type of trial update or analyst upgrade to get us back to high single digits. Still....I'll take it.
10 bucks says he's a liberal, like Cramer.
Jeezus! This sucks and pop or no pop, I'm bailing today.
You can't continue to burn money and make investors wait forever to deliver. Repeatedly extending trials gets old,